Showing results (771-780 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|January 1, 1996
A simplified and efficient synthesis of 5,10-dideaza-5,6,7,8-tetrahydrofolic acid (DDATHF)E C Taylor, R Chaudhari, K LeeInvestigational New Drugs|January 1, 1996
Biochemistry and pharmacology of glycinamide ribonucleotide formyltransferase inhibitors: LY309887 and lometrexolL G Mendelsohn, C Shih, R M Schultz, et al.Investigational New Drugs|January 1, 1996
AG2034: a novel inhibitor of glycinamide ribonucleotide formyltransferaseT J Boritzki, C A Barlett, C Zhang, et al.Investigational New Drugs|January 1, 1996
Influence of minor groove binders on the eukaryotic topoisomerase II cleavage reaction with 41 base pair model oligonucleotidesA Bell, L Kittler, G Löber, et al.Investigational New Drugs|January 1, 1996
Evaluation of 2,6-diamino-N-([1-(1-oxotridecyl)-2-piperidinyl]methyl)- hexanamide (NPC 15437), a protein kinase C inhibitor, as a modulator of P-glycoprotein-mediated resistance in vitroE C Sha, M C Sha, S H KaufmannInvestigational New Drugs|January 1, 1996
Phase II study of docetaxel (taxotere) in patients with previously untreated extensive small cell lung cancerJ Latreille, Y Cormier, H Martins, et al.Investigational New Drugs|January 1, 1996
Phase II trial of edatrexate in patients with metastatic colorectal cancerG H Clamon, C E Riggs, R Dreicer, et al.Investigational New Drugs|May 1, 1993
Cerebrospinal fluid pharmacokinetics and toxicology of intraventricular and intrathecal arabinosyl-5-azacytosine (fazarabine, NSC 281272) in the nonhuman primateR L Heideman, C McCully, F M Balis, et al.Investigational New Drugs|January 1, 1995
P-glycoprotein mediated resistance to 5'-nor-anhydro-vinblastine (Navelbine)D J Adams, V C KnickInvestigational New Drugs|January 1, 1995
Preclinical antitumor activity of ethyldeshydroxysparsomycin in combination with cisplatinH P Hofs, D J Wagener, V De Valk-Bakker, et al.Pageof 372